Ted R. Mikuls

Ted R. Mikuls

Rheumatology

10170 Nicholas Street
Omaha, NE 68114

Last Updated: 09/26/2026

Save publications for later

Sign Up

Not sure about your diagnosis?

Check Your Symptoms

Found 368 publications

Intratracheal interleukin-10 administration reduces acute lung injury induced by sulfur dioxide exposure in mice.

Intratracheal interleukin-10 administration reduces acute lung injury induced by sulfur dioxide exposure in mice.

Journal: Physiological reports

Published: July 21, 2026

Real-World Treatment Patterns in Rheumatoid Arthritis-Associated Interstitial Lung Disease.

Real-World Treatment Patterns in Rheumatoid Arthritis-Associated Interstitial Lung Disease.

Journal: ACR open rheumatology

Published: April 29, 2026

Treat-to-Target Urate-lowering Therapy: Lessons Learned from the STOP Gout Study.

Treat-to-Target Urate-lowering Therapy: Lessons Learned from the STOP Gout Study.

Journal: Current rheumatology reports

Published: April 16, 2026

Associations of Frailty With the Risk of Incident Cancer and Cancer-Related Mortality in Veterans With Rheumatoid Arthritis.

Associations of Frailty With the Risk of Incident Cancer and Cancer-Related Mortality in Veterans With Rheumatoid Arthritis.

Journal: Arthritis care & research

Published: April 06, 2026

Extending Service Beyond Active Duty: Generalizability of Rheumatoid Arthritis Research Conducted Among U.S. Veterans.

Extending Service Beyond Active Duty: Generalizability of Rheumatoid Arthritis Research Conducted Among U.S. Veterans.

Journal: Arthritis care & research

Published: April 02, 2026

Certolizumab Inhibits Radiographic Progression in Patients with Early Rheumatoid Arthritis and High Rheumatoid Factor Levels: A Pooled, Post‑Hoc Analysis of the Phase 3 C‑EARLY and C‑OPERA Trials.

Certolizumab Inhibits Radiographic Progression in Patients with Early Rheumatoid Arthritis and High Rheumatoid Factor Levels: A Pooled, Post‑Hoc Analysis of the Phase 3 C‑EARLY and C‑OPERA Trials.

Journal: Joint bone spine

Published: February 24, 2026

Certolizumab inhibits radiographic progression in patients with early rheumatoid arthritis and high rheumatoid factor levels: A pooled, post-hoc analysis of the phase 3 C-EARLY and C-OPERA trials.

Certolizumab inhibits radiographic progression in patients with early rheumatoid arthritis and high rheumatoid factor levels: A pooled, post-hoc analysis of the phase 3 C-EARLY and C-OPERA trials.

Journal: Joint bone spine

Published: February 24, 2026

Epidemiology and outcomes of rheumatoid arthritis.

Epidemiology and outcomes of rheumatoid arthritis.

Journal: Current opinion in rheumatology

Published: January 29, 2026

Blocking interleukin 33 reduces joint, systemic, and lung inflammatory responses in the combined collagen-induced arthritis-inhalant endotoxin exposure model.

Blocking interleukin 33 reduces joint, systemic, and lung inflammatory responses in the combined collagen-induced arthritis-inhalant endotoxin exposure model.

Journal: The Journal of pharmacology and experimental therapeutics

Published: January 23, 2026

Frailty Predicts Incident Osteoporotic Fractures in Veterans with Rheumatoid Arthritis.

Frailty Predicts Incident Osteoporotic Fractures in Veterans with Rheumatoid Arthritis.

Journal: Arthritis care & research

Published: January 21, 2026

Targeted Treatment for Hyperuricemia: The Drug Pipeline.

Targeted Treatment for Hyperuricemia: The Drug Pipeline.

Journal: Drugs & aging

Published: January 09, 2026

Inhalant Exposures and the Risk of Rheumatoid Arthritis and Rheumatoid Arthritis-Associated Interstitial Lung Disease.

Inhalant Exposures and the Risk of Rheumatoid Arthritis and Rheumatoid Arthritis-Associated Interstitial Lung Disease.

Journal: Cardiovascular toxicology

Published: December 31, 2025

Showing 1-12 of 368

Last Updated: 09/26/2026